Show an ad over header. AMP

Trump plans to aggressively promote vaccine and therapeutic news at coronavirus briefings

Top Trump advisers and GOP leadership have told the president in recent weeks that he needs to switch gears on the coronavirus and go all in on messaging about progress on vaccines and therapeutics.

The big picture: The goal is to try to shift the focus of the election conversation to who would be better at reviving the economy. Administration officials say this is a key reason Trump restarted his briefings this week and that this rhetoric will only accelerate in the weeks to come.


Why it matters: White House and Trump campaign officials have been in panic mode over recent polls showing Trump trailing Joe Biden in swing states just 100 days away from the election.

  • They see this new strategy of leaning hard into the progress on therapeutics and vaccine R&D as the fastest way to restore confidence in Trump and avoid having the election be a referendum on his handling of the pandemic.

The plan: When scientists and health care researchers make big strides on vaccine and therapeutic development, the White House wants Trump at the podium, delivering the good news himself.

  • He'll also largely continue to deliver these messages alone.
  • Two administration officials said this is a deliberate choice. The White House wants Trump to speak directly to the American people and have them make no mistake that this is coming from him — not Dr. Deborah Birx or Dr. Anthony Fauci.

The message: Trump will assert that, under his leadership, the coronavirus task force has helped make major advancements in the ability to treat COVID-19.

  • On therapeutics: "If you get ill from COVID, you have a significantly lower chance of getting seriously ill or dying since we have remdesivir, convalescent plasma, and steroids to treat the virus — which we didn’t have in the early stages of the outbreak," a White House official said.
  • On vaccines: "We are making significant progress on a vaccine and working simultaneously on a distribution plan so that when we reach it we can get it to hundreds of millions of people immediately," the official told Axios.

What we're hearing: "I think it's pretty clear to everyone that getting a vaccine, getting therapeutics that work is the golden key to unlocking the economy and stopping the crisis," a source close to the Trump campaign told Axios.

  • "The polling has been clear on this stuff. People want Trump to take it seriously. And I do think this past week was probably the first week in a couple of months since the [George] Floyd protests started where I thought Trump won every single day of the week."

Reality check: It's nearly impossible that a vast majority of the public will have access to a vaccine by 2021, let alone before the election. And that assumes a vaccine proves to work, Axios' Bob Herman writes.

  • Therapeutics are still in development, and many have shown promising leads. But the timeframe for getting these to market before Nov. 3 is a very ambitious goal, and none — including remdesivir — have come close to presenting a cure to the virus.
  • In the absence of a vaccine or more effective treatments, the main way to save lives and slow the spread of the virus is still through masks, social distancing, avoiding large gatherings and a slow approach to reopening businesses or schools — the steps Trump has resisted, Axios’ Sam Baker notes. Unless those gain more traction, cases and deaths will continue to pile up.

The bottom line: "If he can keep having these types of weeks, where he stays on message and offers people a light at the end of the COVID tunnel, he's gonna be in a lot stronger position to win reelection than I think a lot of people think right now," an administration official said.

  • But keeping Trump on message has never been an easy feat, and a lot can happen between now and November.

COVID-19 shows a bright future for vaccines

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

Keep reading... Show less

Beware a Thanksgiving mirage

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.

Keep reading... Show less

Trump pardons Michael Flynn

President Trump on Wednesday pardoned his former national security adviser Michael Flynn, who pleaded guilty in December 2017 to lying to the FBI about his Russian contacts.

Why it matters: It is the first of multiple pardons expected in the coming weeks, as Axios scooped last night.

This is a breaking story and will be updated with more details.

The emerging cybersecurity headaches awaiting Biden

The incoming administration will face a slew of cybersecurity-related challenges, as Joe Biden takes office under a very different environment than existed when he was last in the White House as vice president.

The big picture: President-elect Biden's top cybersecurity and national security advisers will have to wrestle with the ascendancy of new adversaries and cyberpowers, as well as figure out whether to continue the more aggressive stance the Trump administration has taken in cyberspace.

Keep reading... Show less

Past friction between Biden and Erdoğan foreshadows future tensions

Ankara — The incoming Biden administration's foreign policy priorities and worldview will collide with those of the Turkish government on several issues.

Why it matters: The U.S. needs its NATO ally Turkey for its efforts to contain Russia, counter Iran and deal with other crises in the Middle East. But relations between Biden and Turkish President Recep Tayyip Erdoğan are expected to be strained.

Keep reading... Show less

Tesla's wild rise and European plan

Data: FactSet; Chart: Axios Visuals

Tesla's market capitalization blew past $500 billion for the first time Tuesday.

Why it matters: It's just a number, but kind of a wild one. Consider, via CNN: "Tesla is now worth more than the combined market value of most of the world's major automakers: Toyota, Volkswagen, GM, Ford, Fiat Chrysler and its merger partner PSA Group."

Keep reading... Show less

China's Xi Jinping congratulates Biden on election win

Chinese President Xi Jinping sent a message to President-elect Biden on Wednesday to congratulate him on his election victory, according to the Xinhua state news agency.

Why it matters: China's foreign ministry offered Biden a belated, and tentative, congratulations on Nov. 13, but Xi had not personally acknowledged Biden's win. The leaders of Brazil, Mexico and Russia are among the very few leaders still declining to congratulate Biden.

This story is breaking news. Please check back for updates.

College basketball is back

A new season of college basketball begins Wednesday, and the goal is clear: March Madness must be played.

Why it matters: On March 12, 2020, the lights went out on college basketball, depriving teams like Baylor (who won our tournament simulation), Dayton, San Diego State and Florida State of perhaps their best chance to win a national championship.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories